Bm-sev

Bm-sev has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jun 18, 2026: “Dual-engineered small extracellular vesicles targeted delivery miR-126 for reducing age-related bone loss”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on bm-sev

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Animals1

What did studies of bm-sev find?

2

Studies of bm-sev measured 2 outcomes: age-related bone loss and type H vessels.

Age-related bone loss

downin rats1

1 study
  1. Bm-sev decreases age-related bone loss in rats (aged femurs).

    Animalsaged femursbone-targeting engineered vesicles (Bm-sEV)femur

More on Age-related bone loss

Type H vessels

upin rats1

1 study
  1. Bm-sev increases type H vessels in rats (aged femurs).

    Animalsaged femursbone-targeting engineered vesicles (Bm-sEV)femur

More on Type H vessels

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months